Rubrik: europharm
(Treffer aus pharmind, Nr. 07, Seite 1078 (2014))
Paraskevova J
EVMPD/XEVPRM Reporting to the European Medicines Agency / The strategy of MEDA Pharma · Paraskevova J · MEDA Pharma GmbH & Co, KG, Bad Homburg
The approach by MEDA Pharma how to reach this extraordinarily challenging goal, XEVPRM reporting 2012, is described in this article. The concept included two implementation phases. The first one answered the requirements in the year 2012. The second referred to the regular and continuous reporting to the European Medicines Agency (EMA). Perspectives for 2014 corresponding to the current EMA requirements are touched.